Search for tag 'Healthcare'

14 results Number of Results per Page
  1. Price of medication

    Medicines: how much should they cost?

    Although medical progress is allowing us to treat more and more diseases, innovative medicines tend to be expensive. Expenses are rising constantly in the healthcare sector as a result, putting accessibility and affordability under pressure. Which criteria does the Belgian Commission for Reimbursement of Medicines apply and what could be improved? These questions are answered in a study based on RIZIV data, in the framework of the Roche Chair at the Vlerick Healthcare Management Centre.

  2. White paper priorities in healthcare

    Setting Priorities in Healthcare

    Healthcare organisations are under growing pressure to give patients better outcomes and add value for all stakeholders. And in recent years, there has been an increase in innovation across the sector – with the arrival of emerging technologies and pharmaceutical
    advances that have the potential to enhance the lives of patients around the world.

  3. Hospital network formation

    Hospital networks: quo vadis?

    Hospitals are increasingly joining forces in networks of different types, sometimes with other healthcare players. This is an unmistakable trend, but forming networks is also an important strategic decision. How can hospitals ensure the right decisions are taken, both today and tomorrow, guaranteeing a robust, resilient and versatile organisation in the long run? Changes are rapidly succeeding one another, but who knows what healthcare will be like fifteen years from now and what the best set-up would be for these networks? No one can predict the future. However, despite all the uncertainties, a scenario analysis can help in the decision-making process.

  4. UCB

    Pharma and data as gospel

    Developing drugs is a time-consuming process. In order to speed it up, the Belgian biopharmaceuticals producer UCB has decided to switch to a data-driven organisation. It was necessary to ‘convert’ the entire company to achieve this, says CIO Herman De Prins.

  5. Innovative cancer treatments: how much are we willing to pay?

    One man in three and one woman in four will develop cancer before their 75th birthday. In Belgium, cancer is the second major cause of disease burden after cardiovascular diseases and it is unlikely this will change in the foreseeable future. Increasingly better but more expensive cancer therapies are becoming available. Needless to say, in these times of austerity, the public budget for cancer treatment is under pressure. How can we ensure all patients continue to have access to these expensive but potentially life-saving medicines at a price society can afford, while at the same time encouraging pharmaceutical companies to innovate?

  6. An engaged customer is a return customer

    Engaging customers with your firm is good for business. You can even go as far as having the customer do part of the job – like using the self-scan in the supermarket. But how do you encourage and manage this effectively? And are there any pitfalls?

  7. The growing importance of traceability in the health care sector

    Faulty breast implant scandals, evolutions in the legal framework, counterfeit products and patient safety are all issues that have highlighted the importance of traceability in the health care sector. The Vlerick Healthcare Supply Chain Research Network analysed in which fields the various players in the supply chain can make the greatest profits thanks to a more efficient track-and-trace process. Moreover, the main drivers and obstacles were identified.

  8. The hospital pharmacy of tomorrow

    What is the core activity of a hospital pharmacy? To provide the right drugs and other pharmaceutical products to the right patient at the right time, in the right dose and in the right condition. Currently, there is a trend towards expanding the contribution of the hospital pharmacy to include services such as information provision, advice and follow-up. ‘However, the question is whether the present organisation of the hospital pharmacy can support this trend,’ says Brecht Cardoen, Assistant Professor in Service Operations Management and head of Vlerick research centre MINOZ.

  9. co-creation

    Get ready for a co-creative economy

    In an increasingly dynamic marketplace – characterised by demanding customers, increased competition, and economic downturns – companies are starting to engage their customers in innovating their services and creating value. This doctoral dissertation provides insight into the conditions under which firms and their stakeholders can benefit from value co-creation. It also provides a unifying value co-creation framework and presents the implications of this framework for business practitioners who are interested in value co-creation as a customer engagement strategy.

  10. Humor

    Investments in personalised medicine reduce healthcare costs dramatically

    Investments in better ICT and diagnostic technologies that make highly personalised healthcare possible really do pay off. Not only do patients benefit, but there are economic gains too. Particularly for breast cancer and cardiovascular disease – two of the most common health conditions today – the long-term costs can be dramatically reduced by better screening of patients and easier access to treatment and medication. This opens the door for new and innovative initiatives from the business world.

14 results Number of Results per Page